Biodesix Lowers FY2026 Sales Guidance from $108.000M-$114.000M to $101.000M-$103.000M vs $111.817M Est
Benzinga Newsdesk 11 hours ago
NewsGuidance
Biodesix (NASDAQ:BDSX) lowers FY2026 sales outlook from $108.000 million-$114.000 million to $101.000 million-$103.000 million vs $111.817 million estimate.
Biodesix (NASDAQ:BDSX) lowers FY2026 sales outlook from $108.000 million-$114.000 million to $101.000 million-$103.000 million vs $111.817 million estimate.